These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 7883736

  • 1. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM, Cellar JS, Bowers MB, Nelson JC, Takeshita J, Zigun B.
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [Abstract] [Full Text] [Related]

  • 2. Treatment of acute neuroleptic-induced movement disorders.
    Tonda ME, Guthrie SK.
    Pharmacotherapy; 1994 Mar; 14(5):543-60. PubMed ID: 7997388
    [Abstract] [Full Text] [Related]

  • 3. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.
    Kim JH, Jung HY, Kang UG, Jeong SH, Ahn YM, Byun HJ, Ha KS, Kim YS.
    Mov Disord; 2002 Nov; 17(6):1354-9. PubMed ID: 12465082
    [Abstract] [Full Text] [Related]

  • 4. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998 Nov; 59 Suppl 12():23-7. PubMed ID: 9766616
    [Abstract] [Full Text] [Related]

  • 5. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA, Brecher M, Paulsson B.
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [Abstract] [Full Text] [Related]

  • 6. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study.
    Weiden PJ, Mann JJ, Haas G, Mattson M, Frances A.
    Am J Psychiatry; 1987 Sep; 144(9):1148-53. PubMed ID: 2888321
    [Abstract] [Full Text] [Related]

  • 7. Motor and mental aspects of acute extrapyramidal syndromes.
    Casey DE.
    Acta Psychiatr Scand Suppl; 1994 Sep; 380():14-20. PubMed ID: 7914042
    [Abstract] [Full Text] [Related]

  • 8. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects.
    Mazure CM, Nelson JC, Jatlow PI, Kincare P, Bowers MB.
    J Clin Psychiatry; 1990 Aug; 51(8):330-4. PubMed ID: 2199431
    [Abstract] [Full Text] [Related]

  • 9. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG, Kopala LC, Rabinowitz J.
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [Abstract] [Full Text] [Related]

  • 10. Movement disorders associated with neuroleptic treatment.
    Wirshing WC.
    J Clin Psychiatry; 2001 May; 62 Suppl 21():15-8. PubMed ID: 11584982
    [Abstract] [Full Text] [Related]

  • 11. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
    Modestin J, Wehrli MV, Stephan PL, Agarwalla P.
    Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
    [Abstract] [Full Text] [Related]

  • 12. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A.
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [Abstract] [Full Text] [Related]

  • 13. [Extrapyramidal effects of antipsychotic drugs].
    Kulisevsky J, Otermin P.
    Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
    [Abstract] [Full Text] [Related]

  • 14. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM, Annable L, Bélanger MC, Chouinard G.
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [Abstract] [Full Text] [Related]

  • 15. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
    Cortese L, Caligiuri MP, Williams R, Schieldrop P, Manchanda R, Malla A, Harricharan R.
    J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
    [Abstract] [Full Text] [Related]

  • 16. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
    McManus DQ, Arvanitis LA, Kowalcyk BB.
    J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L, Casey DE, Hoffman WF, McCall AL.
    Arch Intern Med; 1993 Jun 28; 153(12):1469-75. PubMed ID: 8512437
    [Abstract] [Full Text] [Related]

  • 19. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK, Zalar B, Breskvar K, Dolzan V.
    J Psychopharmacol; 2006 Nov 28; 20(6):829-33. PubMed ID: 16478753
    [Abstract] [Full Text] [Related]

  • 20. Clozapine, negative symptoms, and extrapyramidal side effects.
    Kane JM, Safferman AZ, Pollack S, Johns C, Szymanski S, Kronig M, Lieberman JA.
    J Clin Psychiatry; 1994 Sep 28; 55 Suppl B():74-7. PubMed ID: 7961579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.